South & Central America Blood Gas and Electrolyte Analyzer Market Forecast to 2031 - Regional Analysis

Description

List of Tables

The South & Central America blood gas and electrolyte analyzer market was valued at US$ 85.56 million in 2023 and is projected to reach US$ 134.41 million by 2031; it is estimated to record a CAGR of 5.8% from 2023 to 2031.

New Product Launches and Approvals Fuel South & Central America Blood Gas and Electrolyte Analyzer Market

The development of the healthcare industry has led to a rise in the demand for blood gas and electrolyte analyzers among healthcare providers across the world. This increased demand contributes to new product developments, product launches, and approvals on a global level. In addition, major market players are involved in research and development activities to ensure the innovation and development of efficient products. Following are a few of the recent product launches and developments:

In July 2023, Siemens Healthineers launched the new Atellica CI Analyser for clinical chemistry and immunoassay testing. The US Food and Drug Administration (FDA) permitted the analyzer before its debut. It is currently accessible in several international locations. In July 2022, at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (2022 AACC), EDAN Instruments, Inc. announced the launch of the first-ever point-of-care (POC) fluorescence-based CO-OX blood gas and chemistry analysis system, i20. The system has over 45 parameters, ranging from blood gases to electrolytes to CO-oximetry. Thus, an increase in product developments, launches, and strategic collaborations among market players is likely to create ample opportunities for the blood gas and electrolyte analyzers market in the coming years.

South & Central America Blood Gas and Electrolyte Analyzer Market Overview

Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia are among the major countries in the Rest of South & Central America. These countries are improving their healthcare infrastructure by allowing new players to enter the market, which, in turn, increases the demand for blood gas and electrolyte analyzers. In addition, the countries in the region are investing and taking an interest in improving their healthcare services and focusing on primary and advanced care. As a result, the number of healthcare settings in these countries is expected to grow in the coming years. With the growing aging population, rising prevalence of chronic conditions can be witnessed, which would increase the demand for blood gas and electrolyte analyzers across the Rest of South & Central America during the forecast period.

South & Central America Blood Gas and Electrolyte Analyzer Market Revenue and Forecast to 2031 (US$ Million)

South & Central America Blood Gas and Electrolyte Analyzer Market Segmentation

The South & Central America blood gas and electrolyte analyzer market is categorized into product, end user, and country.

Based on product, the South & Central America blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held the largest market share in 2023.

By end user, the South & Central America blood gas and electrolyte analyzer market is segmented into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held the largest market share in 2023.

By country, the South & Central America blood gas and electrolyte analyzer market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America blood gas and electrolyte analyzer market share in 2023.

Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd. are some of the leading companies operating in the South & Central America blood gas and electrolyte analyzer market.

Product Code: BMIRE00030939

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Blood Gas and Electrolyte Analyzer Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Number of Patients in Emergency Units of Hospitals
- 4.1.2 Rising Adoption of Point-of-Care Diagnostics
4.2 Market Restraints
- 4.2.1 High Costs of Analysers
4.3 Market Opportunities
- 4.3.1 New Product Launches and Approvals
4.4 Future Trends
- 4.4.1 Automation and Artificial Intelligence in Blood Gas and Electrolyte Analyzer
4.5 Impact of Drivers and Restraints:

5. Blood Gas and Electrolyte Analyzer Market - South & Central America Market Analysis

5.1 Blood Gas and Electrolyte Analyzer Market Revenue (US$ Million), 2021-2031
5.2 Blood Gas and Electrolyte Analyzer Market Forecast Analysis

6. South & Central America Blood Gas and Electrolyte Analyzer Market Analysis - by Product

6.1 Blood Gas Analyzer
- 6.1.1 Overview
- 6.1.2 Blood Gas Analyzer: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Electrolyte Analyzer
- 6.2.1 Overview
- 6.2.2 Electrolyte Analyzer: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Combined Analyzer
- 6.3.1 Overview
- 6.3.2 Combined Analyzer: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
6.4 Others
- 6.4.1 Overview
- 6.4.2 Others: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)

7. South & Central America Blood Gas and Electrolyte Analyzer Market Analysis - by End User

7.1 Hospitals and Clinics
- 7.1.1 Overview
- 7.1.2 Hospitals and Clinics: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Clinical and Diagnostic Laboratories
- 7.2.1 Overview
- 7.2.2 Clinical and Diagnostic Laboratories: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Homecare
- 7.3.1 Overview
- 7.3.2 Homecare: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Blood Gas and Electrolyte Analyzer Market - Country Analysis

8.1 South & Central America Market Overview
- 8.1.1 South & Central America: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast Analysis - by Country
  - 8.1.1.1 South & Central America: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast Analysis - by Country
  - 8.1.1.2 Brazil: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.2.1 Brazil: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
    - 8.1.1.2.2 Brazil: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
  - 8.1.1.3 Argentina: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.3.1 Argentina: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
    - 8.1.1.3.2 Argentina: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
  - 8.1.1.4 Rest of South & Central America: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.4.1 Rest of South & Central America: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
    - 8.1.1.4.2 Rest of South & Central America: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User

9. Industry Landscape

9.1 Overview
9.2 Organic Growth Strategies
- 9.2.1 Overview
9.3 Brand Share/Revenue- 2022

10. Company Profiles

10.1 Abbott Laboratories
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Dalko Diagnostics Private Limited
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Erba Diagnostics Mannheim GmbH
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Hoffmann-La Roche Ltd
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Medica Corporation
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 Nova Biomedical Corporation
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Siemens Healthineers AG
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Werfen SA
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Radiometer Medical ApS
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
10.10 Sensa Core Medical Instrumentation Pvt Ltd
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms